PubMed 36995625

PubMed ID: 36995625

View on PubMed
Delivery of CRISPR-Cas12a Ribonucleoprotein Complex for Genome Editing in an Embryogenic Citrus Cell Line.
Authors: Fang Hong, Culver James N, Niedz Randall P, Qi Yiping
Journal: Methods in molecular biology (Clifton, N.J.) (Methods Mol Biol), Vol.2653(), 2023

DOI: 10.1016/0003-2697(76)90527-3 PMCID: 4353184

Abstract
Clustered regularly interspaced short palindromic repeats (CRISPR) technology is a powerful genome editing tool. Recently developed CRISPR-Cas12a system confers several advantages over CRISPR-Cas9, making it ideal for use in plant genome editing and crop improvement. While traditional transformation methods based on plasmid delivery pose concerns associated with transgene integration and off-target effects, CRISPR-Cas12a delivered as ribonucleoproteins (RNPs) can effectively alleviate these potential issues. Here we present a detailed protocol for LbCas12a-mediated genome editing using RNP delivery in Citrus protoplasts. This protocol provides a comprehensive guideline for RNP component preparation, RNP complex assembly and delivery, and editing efficiency assessment.
Publication Types
Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't
Keywords
CRISPR-Cas12a Citrus Embryogenic cell line Genome editing Protoplast transformation Ribonucleoproteins Transgene-free
Related Articles